•
GN
GNTA
Genenta Science S.p.A. American Depositary Shares
polygon--
Price Chart
Market Cap
30.93M
Volume
26.54K
52W High
$10.00
52W Low
$1.26
Open
$1.32
Prev Close
$1.32
Day Range
1.30 - 1.40
About Genenta Science S.p.A. American Depositary Shares
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Latest News
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
GlobeNewswire Inc.•Nov 24
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
GlobeNewswire Inc.•Oct 27
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production
GlobeNewswire Inc.•Oct 24
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
GlobeNewswire Inc.•Apr 15
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
Benzinga•Feb 27
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
GlobeNewswire Inc.•Jan 9
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
GlobeNewswire Inc.•May 6
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
GlobeNewswire Inc.•Feb 8